Clinical trial
New Chemotherapy Regimens and Biomarkers for Chagas Disease
NCT03981523 is registered in ClinicalTrials.gov with University of Texas, El Paso as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- New Chemotherapy Regimens and Biomarkers for Chagas Disease
- Lead sponsor
- University of Texas, El Paso
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 18, 2019
- Completion date
- May 31, 2024
- Enrollment
- 450 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
chagas disease, trypanosoma cruzi infection